Antifungal and Antitumour Activity of Triorganotin Compounds
Author Information
Author(s): Libor Dostfil, Ale Rfii6ka, Roman Jambor, Vladimir Buchta, Petra Kubanovfi, Jaroslav Holo6ek
Primary Institution: University of Pardubice
Hypothesis
The study investigates the in vitro antifungal and antitumour activities of various triorganotin(IV) compounds.
Conclusion
The study found that some triorganotin compounds exhibit antifungal activity, but the tested diphenyltin(IV) complexes were inactive against all tumour cell lines.
Supporting Evidence
- The in vitro antifungal activity was compared with conventional drugs like ketoconazole and fluconazole.
- Compounds 1 and 3 were found to be inactive against the tested fungi.
- Both diphenyltin(IV) complexes 4 and 5 were inactive against all seven tumour cell lines tested.
Takeaway
Some chemicals can fight fungi, but the ones tested here didn't work against cancer cells.
Methodology
The study used in vitro testing methods including microdilution broth for antifungal activity and specific protocols for antitumour screening.
Limitations
The tested compounds showed inactivity against all tumour cell lines despite their antifungal activity.
Want to read the original?
Access the complete publication on the publisher's website